Publications by authors named "Kim Clar"

Claim this Profile
P
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Jonas S Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Kim L Clar

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression.
Susanne M Rittig, Martina S Lutz, Kim L Clar, Yanjun Zhou, Korbinian N Kropp

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.
Kim L Clar, Lisa M Weber, Bastian J Schmied, Jonas S Heitmann, Maddalena Marconato

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
Yanjun Zhou, Jonas S Heitmann, Kim L Clar, Korbinian N Kropp, Martina Hinterleitner

Cancer Immunol Immunother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
Ilona Hagelstein, Martina S Lutz, Moritz Schmidt, Jonas S Heitmann, Elke Malenke, Kim L Clar

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Cells Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid Transition.
Andrew W Holle, Neethu Govindan Kutty Devi, Kim Clar, Anthony Fan, Taher Saif

Nano Lett· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.
Kim L Clar, Clemens Hinterleitner, Pascal Schneider, Helmut R Salih, Stefanie Maurer

Cancers (Basel)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma.
Korbinian N Kropp, Stefanie Maurer, Kathrin Rothfelder, Bastian J Schmied, Kim L Clar

Cancer Immunol Immunother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis